» Articles » PMID: 38154556

Artificial Intelligence Tools for the Diagnosis of Eosinophilic Esophagitis in Adults Reporting Dysphagia: Development, External Validation, and Software Creation for Point-of-Care Use

Abstract

Background: Despite increased awareness of eosinophilic esophagitis (EoE), the diagnostic delay has remained stable over the past 3 decades. There is a need to improve the diagnostic performance and optimize resources allocation in the setting of EoE.

Objective: We developed and validated 2 point-of-care machine learning (ML) tools to predict a diagnosis of EoE before histology results during office visits.

Methods: We conducted a multicenter study in 3 European tertiary referral centers for EoE. We built predictive ML models using retrospectively extracted clinical and esophagogastroduodenoscopy (EGDS) data collected from 273 EoE and 55 non-EoE dysphagia patients. We validated the models on an independent cohort of 93 consecutive patients with dysphagia undergoing EGDS with biopsies at 2 different centers. Models' performance was assessed by area under the curve (AUC), sensitivity, specificity, and positive and negative predictive values (PPV and NPV). The models were integrated into a point-of-care software package.

Results: The model trained on clinical data alone showed an AUC of 0.90 and a sensitivity, specificity, PPV, and NPV of 0.90, 0.75, 0.80, and 0.87, respectively, for the diagnosis of EoE in the external validation cohort. The model trained on a combination of clinical and endoscopic data showed an AUC of 0.94, and a sensitivity, specificity, PPV, and NPV of 0.94, 0.68, 0.77, and 0.91, respectively, in the external validation cohort.

Conclusion: Our software-integrated models (https://webapplicationing.shinyapps.io/PointOfCare-EoE/) can be used at point-of-care to improve the diagnostic workup of EoE and optimize resources allocation.

Citing Articles

Optimal Assessment, Treatment, and Monitoring of Adults with Eosinophilic Esophagitis: Strategies to Improve Outcomes.

Visaggi P, Ghisa M, Vespa E, Barchi A, Mari A, Pasta A Immunotargets Ther. 2024; 13:367-383.

PMID: 39071859 PMC: 11283784. DOI: 10.2147/ITT.S276869.


A clinical predictive model identifies pediatric patients at risk for eosinophilic esophagitis.

Borinsky S, Miller T, Dellon E Dig Liver Dis. 2024; 56(12):2045-2051.

PMID: 38972789 PMC: 11602386. DOI: 10.1016/j.dld.2024.06.019.


Target Trial Emulation: Improving the Quality of Observational Studies in Inflammatory Bowel Disease Using the Principles of Randomized Trials.

Honap S, Danese S, Peyrin-Biroulet L Inflamm Bowel Dis. 2024; 31(3):843-849.

PMID: 38862178 PMC: 11879188. DOI: 10.1093/ibd/izae131.


The Dual Lens of Endoscopy and Histology in the Diagnosis and Management of Eosinophilic Gastrointestinal Disorders-A Comprehensive Review.

Barchi A, Vespa E, Passaretti S, DellAnna G, Fasulo E, Yacoub M Diagnostics (Basel). 2024; 14(8).

PMID: 38667503 PMC: 11049211. DOI: 10.3390/diagnostics14080858.